Spirometer Market to Grow at a CAGR of 8.2% from 2026 to 2034; Increasing Burden of Chronic Respiratory Diseases is Fostering Market Growth

The global spirometer market size was valued at USD 815.6 million in 2025. The market is set to grow from USD 892.9 million in 2026 to USD 1,675.2 million by 2034, exhibiting a CAGR of 8.2% over the forecast period. Fortune Business Insights™ presents this information in its report titled “Spirometer Market Size, Share & Industry Analysis, By Product Type (Devices, Software, and Accessories & Consumables), By Type (Volume Measurement and Peak Flow Meters), By Application (Chronic Obstructive Pulmonary Disorder (COPD), Asthma, and Others), By End User (Hospitals, Diagnostic Centers, Homecare Settings, Physician/Primary Care Offices or Clinics, and Other Facilities), and Regional Forecast, 2026-2034”

A spirometer is a medical device used to evaluate lung function by measuring the volume and rate of air inhaled and exhaled during respiration. It serves as a key diagnostic tool for identifying and monitoring asthma, chronic obstructive pulmonary disease (COPD), and a broad range of respiratory conditions. The market is expanding due to the increasing burden of chronic respiratory diseases, rising use of spirometry in pharmaceutical research and clinical trials, and greater focus on preventive respiratory healthcare. Furthermore, the transition toward remote patient management and home-based healthcare is driving demand for portable lung-function monitoring solutions. Growing cases of asthma, COPD, cystic fibrosis, neuromuscular respiratory disorders, lung transplant follow-up, and post-viral respiratory complications are reinforcing the need for continuous pulmonary assessment outside conventional clinical settings.

MGC DIAGNOSTICS CORPORATION Unveiled MIR Spirolab to Enhance Portable Pulmonary Function Setting

In July 2024, MGC DIAGNOSTICS CORPORATION introduced the MIR Spirolab, a next-generation all-in-one spirometer that combines portability with advanced diagnostic functionality. Equipped with a durable rechargeable battery, an intuitive7-inch touchscreen display, and integrated respiratory testing capabilities, the device supports efficient pulmonary assessments across hospitals, clinics, and point-of-care settings.

Rapid Innovations in Portable, Handheld, and Connected Spirometry Solutions Propel Market Growth

Growing investments by leading companies in R&D activities are driving the introduction of advanced spirometers that enable earlier and more accurate diagnosis of chronic respiratory diseases such as COPD. Continuous technological advancements are significantly influencing market expansion by improving diagnostic accuracy, operational efficiency, and patient accessibility. The emergence of portable, handheld, wireless, app-connected, cloud-enabled, calibration-free, and AI-assisted spirometry systems is improving test quality, minimizing operator dependency, facilitating remote patient monitoring, and expanding respiratory testing across primary care, home healthcare, occupational health, pharmacies, clinical trials, and decentralized care settings.

For instance, in May 2026, Medical International Research S.p.A. entered into a partnership with Locus Health to integrate advanced spirometry capabilities into the company’s remote patient monitoring (RPM) solutions. The integration strengthens digital respiratory monitoring and supports clinicians with real-time patient insights for more effective clinical decision-making.

However, the substantial cost of advanced spirometry equipment and the complexity of software integration are hindering the spirometer market growth.

Key Companies Emphasize Enhancing Product Offerings to Maintain Their Dominance

Jaeger Medical GmbH and Vitalograph are among the leading participants in the market, supported by their comprehensive product portfolios and strong focus on inorganic growth initiatives across global markets. Their strategic emphasis on expanding capabilities through acquisitions, partnerships, and certifications has strengthened their competitive position. Additionally, a growing focus on obtaining regulatory and software certifications is expected to reinforce their global market presence further.

• In August 2025, Jaeger Medical GmbH received Authority to Operate (ATO) certification for its flagship respiratory diagnostics software platform, SentrySuite, under the U.S. Department of Defense's (DoD) Risk Management Framework (RMF).

Meanwhile, other prominent players, including ndd Medical Technologies and MGC Diagnostics Corporation, continue to enhance market competition through the introduction of advanced spirometry devices and integrated software platforms.

List of Key Players Mentioned in the Report

• ndd Medizintechnik AG (Switzerland)
• COSMED srl (Italy)
• MGC Diagnostics Corporation (U.S.)
• Vitalograph (Ireland)
• Chest M.I., Inc. (Japan)
• Jaeger Medical GmbH (Germany)
• Ganshorn Medizin Electronic GmbH (Germany)
• Medical International Research S.p.A. (MIR) (Italy)
• Midmark Corporation (U.S.)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/spirometers-market-100486

Key Industry Development

• December 2025: COSMED srl expanded its strategic footprint in cardiopulmonary diagnostics, metabolic assessment solutions, and body composition technologies by acquiring Ergometrix S.A., a long-standing Spanish distributor recognized for supplying advanced electronic equipment to the healthcare and rehabilitation industries.

Further Report Findings

• North America emerged as the leading regional market, with revenues increasing from USD 328.3 million in 2024 to USD 358.2 million in 2025. The regional market continues to benefit from the increasing incidence of asthma, broader implementation of pulmonary screening programs, higher healthcare investments, and ongoing innovation in spirometry technologies.
• Europe is expected to witness the second-fastest growth rate, recording a CAGR of 7.7% and attaining a value of USD 205.4 million in 2026. Strong product innovation and sustained R&D investments by top players are boosting demand for advanced spirometry solutions.
• By product type, the devices segment accounted for the largest spirometer market share in 2025. The segment is benefiting from continuous advancements in spirometer technology. Increasing financial support and strategic investments by leading companies are expected to accelerate product development and commercialization.
• In terms of type, the volume measurement segment led the market in 2025. The segment’s leadership is supported by the increasing prevalence of chronic respiratory disorders, established adherence to ATS/ERS spirometry guidelines, and widespread deployment of pulmonary function testing (PFT) systems in hospitals and specialist respiratory clinics.

Table of Segmentation